Mark A Ilgen, PhD
Professor
Office:
2800 Plymouth Road, Bld 16
Ann Arbor, MI 48109
Ann Arbor, MI 48109
Available to mentor
Mark A Ilgen, PhD
Professor
Manage Your Profile
About
Mark Ilgen, PhD is a clinical psychologist and a health services researcher with an interest in improving outcomes for individuals with problematic alcohol and drug use. He is currently the Albert J. Silverman Research Professor of Psychiatric Disorders in the Department of Psychiatry at the University of Michigan and a Research Career Scientist with the VA Center for Clinical Management Research. A core focus of Dr. Ilgen’s work has been on understanding substance use as a risk factor for suicide, including work to test the efficacy of interventions to reduce suicide risk. His research has been funded by the National Institutes of Health, the Department of Veterans Affairs and the Department of Defense. Currently, he is one of the co-Directors of the VA’s National Suicide Prevention Research Impact NeTwork (SPRINT) COnsortia of REsearch (CORE).
Qualifications
-
Postdoctoral FellowVA Palo Alto Health Care System and Stanford University School of Medicine, United States
2003 - 2005
-
PhD, Clinical PsychologyUniversity of Colorado, Boulder, Colorado, 80309, United States
1999 - 2003
-
MA, PsychologyUniversity of Colorado, Boulder, Colorado, United States
1997 - 1999
-
BA, PsychologyMiami University, Oxford, Ohio, United States
1993 - 1997
Center Memberships
-
Center MemberUniversity of Michigan Injury Prevention Center
-
Center MemberEisenberg Family Depression Center
-
Center MemberInstitute for Firearm Injury Prevention
-
Center MemberUniversity of Michigan Addiction Center
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberMM-PKUHSC Joint Institute
Research Overview
Improving the treatment of alcohol and drug use disorders.
Intervening to reduce the risk of suicidal behaviors.
Understanding the relationship between chronic pain and substance use
Recent Publications
-
Ilgen M, Blow F, Piette JD, Goldstick J, Lewis M, Myers MG, Lin LA. Journal of Substance Use and Addiction Treatment, 2026 Dec 1; 191:Journal ArticleTargeting pain to improve opioid use disorder treatment outcomes: Results of a randomized trial
DOI:10.1016/j.josat.2026.210079 -
Ilgen MA, Price AM, Whittington BJ, Goldman P, Hicks BM. American Journal of Public Health, 2026 Jul 22;Journal ArticlePrevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States.
-
Hicks BM, Stearns D, Whittington BJ, Ilgen MA. 2026 Sep 7; PsyArXiv,PreprintCharacteristics Associated with Self-Reported Defensive Gun Use in a National Sample of US
DOI:10.31234/osf.io/tjpsy_v1 -
Goldman P, Hicks B, Ilgen M, Price A. Drug and Alcohol Dependence, 2026 Aug 17;Journal ArticleLinks between Cannabinoid Hyperemesis Syndrome symptoms and drug use, mental health problems, antisocial behavior, and personality in a national survey of adults in the United States
DOI:10.1016/j.drugalcdep.2026.113323 -
Bornheimer LA, Lapidos A, Brdar NM, Kelter AN, Song J, Palaniappan G, Miner C, Campbell M, Hoener K, Florence T, Ilgen MA. Community Mental Health Journal, 2026 Aug 1; 62 (6): 1130 - 1140.Journal ArticlePreparing an Intervention to Increase Engagement with the 988 Suicide and Crisis Lifeline Resource among Community Mental Health Consumers with Schizophrenia Spectrum Disorders
DOI:10.1007/s10597-026-01599-5 PMID: 41758485 -
Bolling C, Cardoni ME, Conroy DA, Price A, Goldstick JE, Bourgoise M, Bonar EE, Krystal A, Ilgen MA, Arnedt JT. BMJ Open, 2026 Jun 1; 16 (6):Journal ArticleCognitive-behavioural therapy for insomnia in adults to decrease cannabis use: study protocol for a randomised controlled trial in a community sample of adults with frequent cannabis use
DOI:10.1136/bmjopen-2026-116524 PMID: 42309658 -
Saulnier KG, Ilgen MA, Lapidos A, Abraham KM, Ganoczy D, Jagusch J, Kim HM, Vega E, Ahmedani BK, Pfeiffer PN. Behaviour Research and Therapy, 2026 Apr 1; 199:Journal ArticleSuicidal ideation trajectories among adults following psychiatric hospitalization
DOI:10.1016/j.brat.2026.104997 PMID: 41740423 -
Bornheimer LA, Lapidos A, Brdar NM, Campbell M, Palaniappan GS, Song J, Miner C, Anderson E, Hoener K, Florence T, Sperry SH, Ilgen MA. Journal of Affective Disorders, 2026 Mar 15; 397:Journal ArticleModifying an intervention to increase use of the 988 suicide and crisis lifeline among patients with bipolar disorder in community mental health
DOI:10.1016/j.jad.2025.120922 PMID: 41421620
Featured News & Stories
Research News
U-M Strategic Initiative Fund announces first 37 funding recipients
This initiative will develop low-cost, at-home biosensors to provide early disease detection, enable timely intervention, and improve quality of life for two chronic diseases.
Health Lab
Are 988 and other mental health crisis lines missing people over 50?
Many people over 50 aren't aware of the 988 mental health crisis line, though some are aware of other crisis lines, suggesting an opportunity to increase awareness and use.
Department News
Psychiatry experts' research highlighted in U-M VP of Research's Michigan Research newsletter
The newsletter featured research by Drs. Amy Bohnert and Srijan Sen; Mark Ilgen; and Mary Heitzeg and Chandra Sripada
Health Lab
What does cannabis 'rescheduling' mean for science and society?
Medical cannabis (marijuana) has been rescheduled on the federal level, which could open the door for much more research than was possible before. Four Michigan Medicine experts comment.
Health Lab
Complex connections among bipolar disorder, substance use and suicide
Discover how bipolar disorder, substance use and suicide risk intersect. Research, clinical and lived experience experts at Michigan Medicine share findings, treatment strategies, and personal insights.
Health Lab
Thoughts don’t kill people, but study suggests options for keeping guns from doing so
Firearm-related thoughts, and the potential for action to prevent people from acting on those thoughts impulsively, are the subject of a new nationally representative study.
